VC-backed Solace Therapeutics adds new board member

Solace Therapeutics said Tuesday that it has named Stacy Enxing Seng to its board of directors. Currently, Enxing Seng is president of Covidien's vascular therapies global business unit. Based in Framingham, Mass., Solace Therapeutics, which is backed by NEA, Saints Capital and Spray Venture Partners, is a maker of medical devices that help treat bladder disorders.

PeopleNorth AmericaUSBriefs